Pediatric Neurology
Volume 31, Issue 1 , Pages 67-70 , July 2004

Subacute sclerosing panencephalitis: a case with fulminant course after ACTH

  • Gul Serdaroglu, MD

      Affiliations

    • Department of Pediatrics, Division of Child Neurology, Ege University Medical School, Izmir, Turkey
    • Corresponding Author InformationCommunications should be addressed to:Dr. Serdaroglu; Ege University Medical School; Department of Pediatrics; Bornova-Izmir, Turkey
    • ,
  • Ayse Kutlu, MD

      Affiliations

    • Department of Pediatrics, Division of Child Neurology, Ege University Medical School, Izmir, Turkey
    • ,
  • Hasan Tekgul, MD

      Affiliations

    • Department of Pediatrics, Division of Child Neurology, Ege University Medical School, Izmir, Turkey
    • ,
  • Sarenur Tutuncuoglu, MD

      Affiliations

    • Department of Pediatrics, Division of Child Neurology, Ege University Medical School, Izmir, Turkey

Received 31 July 2003 ,Accepted 29 December 2003.

References 

  1. Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol. 1996;3:260–269
  2. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol. 1992;21:998–1006
  3. Dyken PR, Cunningham SC, Warn LC. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurol. 1989;5:339–341
  4. Tekgul H, Tutuncuoglu S, Kutukculer N, Dizdarer G, Huseyinov A. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. J Child Neurol. 1999;14:418–421
  5. Marrosu MG, Cianchetti C, Tondi M, et al.  Lymphocyte subpopulation in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis. Acta Neurol Scand. 1983;67:55–63
  6. Vucenovic V, Vranjesevic D. SSPE epidemiology and measles vaccination (Our cases). Neurologija. 1989;38:23–31
  7. Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S, Okan M. Changing epidemiological features of subacute sclerosing panencephalitis. Infection. 2001;29:192–195
  8. Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. Eur J Pediatr. 2002;161:438–441
  9. Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada G. SSPE following neonatal measles infection. Pediatr Neurol. 1999;20:63–65
  10. Zwiauer K, Forstenpointner E, Popow-Kraupp T, Hauser E, Jellinger KA. Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection. Lancet. 1995;345:1124–1125
  11. Risk WS, Haddad FS. The variable natural history of subacute sclerosing panencephalitis (A study of 118 cases from the Middle East). Arch Neurol. 1979;36:610–614
  12. Takayama S, Iwasaki Y, Yamanouchi H, Sugai K, Takashima S, Iwasaki A. Characteristic clinical features in a case of fulminant subacute sclerosing panencephalitis. Brain Dev. 1994;16:132–135
  13. Silva CA, Paula-Barbosa NM, Pereira S, Cruz C. Two cases of rapidly progressive subacute sclerosing panencephalitis (Neuropathological findings). Arch Neurol. 1981;38:109–113
  14. Schwiebert LA, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP. Glucocorticoids inhibition of cytokine production (Relevance to antiallergic actions). J Allergy Clin Immunol. 1996;97:143–152

PII: S0887-8994(04)00053-0

doi: 10.1016/j.pediatrneurol.2003.12.019

Pediatric Neurology
Volume 31, Issue 1 , Pages 67-70 , July 2004

Article Tools

* Image Usage & Resolution